SPNS Stock Forecast 2025-2026
Distance to SPNS Price Targets
SPNS Price Momentum
10 Quality Stocks Worth Considering Now
Researching Sapiens (SPNS) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on SPNS and similar high-potential opportunities.
Latest SPNS Stock Price Targets & Analyst Predictions
Based on our analysis of 8 Wall Street analysts, SPNS has a neutral consensus with a median price target of $28.00 (ranging from $25.00 to $35.00). Currently trading at $27.66, the median forecast implies a 1.2% upside. This outlook is supported by 1 Buy, 2 Hold, and 2 Sell ratings.
The most optimistic forecast comes from Mayank Tandon at Needham, projecting a 26.5% upside. Conversely, the most conservative target is provided by Ashwin Shirvaikar at Citigroup, suggesting a 9.6% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
SPNS Analyst Ratings
SPNS Price Target Range
Latest SPNS Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for SPNS.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 19, 2025 | Needham | Mayank Tandon | Buy | Reiterates | $35.00 |
| Feb 19, 2025 | Barclays | Tavy Rosner | Underweight | Maintains | $28.00 |
| Feb 3, 2025 | Jefferies | Surinder Thind | Hold | Downgrade | $28.00 |
| Nov 12, 2024 | Barclays | Tavy Rosner | Underweight | Maintains | $30.00 |
| Nov 12, 2024 | Needham | Mayank Tandon | Buy | Maintains | $35.00 |
| Aug 2, 2024 | Barclays | Tavy Rosner | Underweight | Maintains | $38.00 |
| Aug 2, 2024 | Needham | Mayank Tandon | Buy | Maintains | $44.00 |
| Aug 2, 2024 | Goldman Sachs | Kevin Kumar | Buy | Maintains | $43.00 |
| May 8, 2024 | Needham | Mayank Tandon | Buy | Reiterates | $38.00 |
| Feb 21, 2024 | Goldman Sachs | Kevin Kumar | Buy | Maintains | $38.00 |
| Feb 21, 2024 | Barclays | Tavy Rosner | Underweight | Maintains | $30.00 |
| Aug 3, 2023 | Barclays | Tavy Rosner | Underweight | Maintains | $28.00 |
| Aug 3, 2023 | Goldman Sachs | Kevin Kumar | Buy | Maintains | $34.00 |
| Aug 2, 2023 | Needham | Mayank Tandon | Buy | Maintains | $35.00 |
| May 5, 2023 | Barclays | Tavy Rosner | Underweight | Downgrade | $24.00 |
| Feb 22, 2023 | Barclays | Tavy Rosner | Equal-Weight | Maintains | $24.00 |
| Feb 22, 2023 | Needham | Mayank Tandon | Buy | Maintains | $24.00 |
| Feb 22, 2023 | Goldman Sachs | Kevin Kumar | Buy | Maintains | $26.00 |
| Jan 23, 2023 | Goldman Sachs | Kevin Kumar | Buy | Initiates | $28.00 |
| Dec 1, 2022 | JP Morgan | Alexei Gogolev | Underweight | Initiates | $20.00 |
Sapiens International Corporation N.V. (SPNS) Competitors
The following stocks are similar to Sapiens based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Sapiens International Corporation N.V. (SPNS) Financial Data
Sapiens International Corporation N.V. has a market capitalization of $1.55B with a P/E ratio of 21.4x. The company generates $542.38M in trailing twelve-month revenue with a 13.3% profit margin.
Revenue growth is +2.6% quarter-over-quarter, while maintaining an operating margin of +16.2% and return on equity of +15.6%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Sapiens International Corporation N.V. (SPNS) Business Model
About Sapiens International Corporation N.V.
Provides software solutions for the insurance industry.
The company generates revenue by offering a comprehensive suite of software solutions tailored for the insurance sector, including life, pension, property, casualty, and reinsurance. Its products focus on enhancing operational efficiency and supporting digital transformation for insurers, with features that streamline claims processing, policy administration, and financial reporting.
Sapiens International Corporation is headquartered in Holon, Israel, and serves a global clientele across North America, Europe, and Asia. The company emphasizes the use of next-generation technologies like cloud computing, artificial intelligence, and data analytics, making its solutions highly configurable to meet diverse regulatory standards and client needs.
Company Information
Sector
Technology
Industry
Software - Application
Employees
5,000
CEO
Mr. Roni Al-Dor
Country
Israel
IPO Year
1998
Website
www.sapiens.comSapiens International Corporation N.V. (SPNS) Latest News & Analysis
Hiscox UK adopts SPNS's insurance platform to enhance efficiency, but faces concerns over currency headwinds impacting financial performance.
Hiscox's transition to SPNS's platform may enhance operational efficiency, potentially improving profitability. However, currency headwinds could impact financial results and investor sentiment.
Sapiens Faces Headwinds To Upside Catalysts
2 days agoSapiens exceeded Q4 2024 earnings estimates but fell short on revenue. The insurance software market is growing, with Sapiens targeting P&C firms. 2025 revenue growth is guided at 2.4%.
Sapiens' Q4 earnings beat indicates profitability, but revenue miss signals growth challenges. Market expansion potential contrasts with modest revenue guidance, affecting investor sentiment.
Sapiens International announced that Hiscox has fully deployed the Sapiens Insurance Platform on the Sapiens Cloud, enhancing operational performance and customer satisfaction.
Hiscox's implementation of Sapiens Insurance Platform signals enhanced operational efficiency and customer satisfaction, potentially leading to improved financial performance and competitiveness in the insurance market.
Sapiens International Corporation will provide its Insurance Platform to Pioneer Insurance in the Philippines to support digital transformation and enhance customer experience.
Pioneer's partnership with Sapiens enhances its digital capabilities, potentially boosting efficiency and customer satisfaction, which can lead to increased market share and profitability.
Sapiens International Corporation N.V. (NASDAQ: SPNS) will hold its Q4 2024 earnings conference call on February 18, 2025, at 9:30 AM ET, featuring key executives and analysts.
The earnings conference call indicates upcoming insights into Sapiens International's financial performance, which can influence stock prices and investor sentiment.
Sapiens International Corporation (NASDAQ: SPNS) announced its fourth-quarter financial results for 2024, ending December 31. Further details are not provided in the excerpt.
Sapiens International's Q4 financial results can influence stock performance, indicating company growth, profitability, and future outlook, which are key factors for investor decisions.
Frequently Asked Questions About SPNS Stock
What is Sapiens International Corporation N.V.'s (SPNS) stock forecast for 2025?
Based on our analysis of 8 Wall Street analysts, Sapiens International Corporation N.V. (SPNS) has a median price target of $28.00. The highest price target is $35.00 and the lowest is $25.00.
Is SPNS stock a good investment in 2025?
According to current analyst ratings, SPNS has 1 Buy ratings, 2 Hold ratings, and 2 Sell ratings. The stock is currently trading at $27.66. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for SPNS stock?
Wall Street analysts predict SPNS stock could reach $28.00 in the next 12 months. This represents a 1.2% increase from the current price of $27.66. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Sapiens International Corporation N.V.'s business model?
The company generates revenue by offering a comprehensive suite of software solutions tailored for the insurance sector, including life, pension, property, casualty, and reinsurance. Its products focus on enhancing operational efficiency and supporting digital transformation for insurers, with features that streamline claims processing, policy administration, and financial reporting.
What is the highest forecasted price for SPNS Sapiens International Corporation N.V.?
The highest price target for SPNS is $35.00 from Mayank Tandon at Needham, which represents a 26.5% increase from the current price of $27.66.
What is the lowest forecasted price for SPNS Sapiens International Corporation N.V.?
The lowest price target for SPNS is $25.00 from Ashwin Shirvaikar at Citigroup, which represents a -9.6% decrease from the current price of $27.66.
What is the overall SPNS consensus from analysts for Sapiens International Corporation N.V.?
The overall analyst consensus for SPNS is neutral. Out of 8 Wall Street analysts, 1 rate it as Buy, 2 as Hold, and 2 as Sell, with a median price target of $28.00.
How accurate are SPNS stock price projections?
Stock price projections, including those for Sapiens International Corporation N.V., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
